Effectiveness and Safety of Ustekinumab for Moderate to Severely Active Crohn’s Disease: Results from an Early Access Program in Brazil

por Chebli, Julio Maria Fonseca, Parra, Rogério Serafim, Flores, Cristina, Moraes, Antonio Carlos, Nones, Rodrigo Bremer, Gomes, Tarcia Nogueira Ferreira, Perdomo, Ana Maria Bravo, Scapini, Gustavo, Zaltman, Cyrla
Publicado 2022